Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Jubilant Pharmova Limited (NSE: JUBLPHARMA), ISIN INE700A01033 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
JUBLPHARMA last traded at ₹1058.60 (-1.14%), with a 52-week range of ₹783.75 to ₹1183.90 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 47.68%, FIIs 15.87%, DIIs 12.40%, mutual funds 8.99%.
EquiSense Score (ECS): 53/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.